sam 2.0 Long Duration Ultrasound Device for Home Use

GUDID 00857599005196

The sustained acoustic medicine, (sam® 2.0) long-duration ultrasound device is intended for the treatment of musculoskeletal injuries and pain relief. sam® 2.0 delivers continuous wave, high-frequency sustained acoustic medicine (3MHz) into deep tissue for up to 4 hours, resulting in improved circulation and nutrient transfer into the injured soft-tissue for multiple hours each day. This sam® mechanism of action improves and accelerates soft tissue healing for tendinopathies, meniscus injuries, osteoarthritis, joint injuries (knee, shoulder, elbow, wrist) and tissue compromised by repetitive and/or overuse injuries. For pain management secondary to injury, sam® 2.0 provides localized, non-systemic pain management and is an appropriate treatment alternative for prescribers seeking to avoid the systemic effects of NSAIDs and opiates. sam® 2.0 is FDA cleared and indicated for prescription home-use, and easily accommodates self-administered treatment by applying the treatment applicator with a hypoallergenic single use pre-filled coupling patch over the soft-tissue injury and activating the battery-operated power controller for autonomous therapeutic delivery.

ZETROZ SYSTEMS, LLC

Physical therapy ultrasound system Physical therapy ultrasound system Physical therapy ultrasound system Physical therapy ultrasound system Physical therapy ultrasound system Physical therapy ultrasound system Physical therapy ultrasound system Physical therapy ultrasound system Physical therapy ultrasound system Physical therapy ultrasound system Physical therapy ultrasound system Physical therapy ultrasound system Physical therapy ultrasound system Physical therapy ultrasound system Physical therapy ultrasound system Physical therapy ultrasound system Physical therapy ultrasound system
Primary Device ID00857599005196
NIH Device Record Keyc245efeb-4d97-4303-8597-7528575521b3
Commercial Distribution StatusIn Commercial Distribution
Brand Namesam 2.0 Long Duration Ultrasound Device for Home Use
Version Model NumberSA271
Company DUNS080128497
Company NameZETROZ SYSTEMS, LLC
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusMR Unsafe
Human Cell/Tissue Productfalse
Device Kitfalse
Device Combination Productfalse
Single Usefalse
Lot Batchfalse
Serial Numbertrue
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Device Identifiers

Device Issuing AgencyDevice ID
GS100857599005196 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

PFWStationary Ultrasonic Diathermy Device For Use In Applying Therapeutic Deep Heat

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2021-12-08
Device Publish Date2021-11-30

Devices Manufactured by ZETROZ SYSTEMS, LLC

00857599005202 - sam X12022-10-07 The sustained acoustic medicine, (sam® X1) long-duration ultrasound device is used in the treatment of musculoskeletal injuries
00857599005196 - sam 2.0 Long Duration Ultrasound Device for Home Use2021-12-08The sustained acoustic medicine, (sam® 2.0) long-duration ultrasound device is intended for the treatment of musculoskeletal injuries and pain relief. sam® 2.0 delivers continuous wave, high-frequency sustained acoustic medicine (3MHz) into deep tissue for up to 4 hours, resulting in improved circulation and nutrient transfer into the injured soft-tissue for multiple hours each day. This sam® mechanism of action improves and accelerates soft tissue healing for tendinopathies, meniscus injuries, osteoarthritis, joint injuries (knee, shoulder, elbow, wrist) and tissue compromised by repetitive and/or overuse injuries. For pain management secondary to injury, sam® 2.0 provides localized, non-systemic pain management and is an appropriate treatment alternative for prescribers seeking to avoid the systemic effects of NSAIDs and opiates. sam® 2.0 is FDA cleared and indicated for prescription home-use, and easily accommodates self-administered treatment by applying the treatment applicator with a hypoallergenic single use pre-filled coupling patch over the soft-tissue injury and activating the battery-operated power controller for autonomous therapeutic delivery.
00857599005196 - sam 2.0 Long Duration Ultrasound Device for Home Use2021-12-08 The sustained acoustic medicine, (sam® 2.0) long-duration ultrasound device is intended for the treatment of musculoskeletal in
00857599005073 - sam2018-07-06 wearable therapeutic ultrasound
00857599005097 - sam coupling patch2018-07-06 coupling patch for use with sam wearable ultrasound device

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.